Table 2 Patient characteristics by Sjögren’s disease status (positive, uncertain, negative) and controls (N = 144)
Variable | Positive N = 21 | Negative N = 57 | Uncertain N = 24 | Control N = 42 | p-value | ||||
|---|---|---|---|---|---|---|---|---|---|
Age, mean ± SD | 52.0 ± 13.4 | 56.5 ± 14.4 | 56.2 ± 13.1 | 57.0 ± 14.1 | 0.58 | ||||
Age Group | N | (%) | N | (%) | N | (%) | N | (%) | |
20–29 | 1 | (4.8) | 2 | (3.5) | 0 | (0.0) | 2 | (4.8) | |
30–39 | 3 | (14.3) | 4 | (7.0) | 2 | (8.3) | 2 | (4.8) | |
40–49 | 5 | (23.8) | 14 | (24.6) | 7 | (29.2) | 7 | (16.7) | |
50–59 | 5 | (23.8) | 11 | (19.3) | 3 | (12.5) | 11 | (26.2) | |
60–69 | 6 | (28.6) | 15 | (26.3) | 10 | (41.7) | 14 | (33.3) | |
70–79 | 1 | (4.8) | 8 | (14.0) | 1 | (4.2) | 5 | (11.9) | |
80+ | 0 | (0.0) | 3 | (5.3) | 1 | (4.2) | 1 | (2.4) | |
Sex, n (%) | 0.30 | ||||||||
Female | 19 | (90.5) | 51 | (89.5) | 24 | 100.0) | 40 | (95.2) | |
Male | 2 | (9.5) | 6 | (10.5) | 0 | (0.0) | 2 | (4.8) | |
Race, n (%) | 0.15 | ||||||||
Black or African American | 5 | (23.8) | 8 | (14.0) | 0 | (0.0) | 8 | (19.0) | |
White | 10 | (47.6) | 28 | (49.1) | 18 | (75.0) | 22 | (52.4) | |
Unknown | 6 | (28.6) | 21 | (36.8) | 6 | (25.0) | 12 | (28.6) | |
Ethnicity, n (%) | 0.76 | ||||||||
Hispanic or Latino | 1 | (5.9) | 3 | (6.1) | 2 | (9.1) | 1 | (2.4) | |
Not Hispanic or Latino | 0 | (0.0) | 1 | (2.0) | 0 | (0.0) | 0 | (0.0) | |
Unknown | 16 | (94.1) | 45 | (91.8) | 20 | (90.9) | 41 | (97.6) | |
Dental insurance, n (%) | 0.47 | ||||||||
Government | 1 | (4.8) | 1 | (1.8) | 0 | (0.0) | 0 | (0.0) | |
Grant | 0 | (0.0) | 1 | (1.8) | 0 | (0.0) | 0 | (0.0) | |
Private | 8 | (38.1) | 14 | (24.6) | 4 | 16.7) | 9 | (21.4) | |
Self-Pay | 12 | (57.1) | 41 | (71.9) | 20 | 83.3) | 33 | (78.6) | |
Medical insurance n (%) | 0.93 | ||||||||
Commercial | 7 | (35.0) | 20 | (37.0) | 6 | (30.0) | 11 | (26.8) | |
Public | 11 | (55.0) | 31 | (57.4) | 13 | (65.0) | 27 | (65.9) | |
Others | 2 | (10.0) | 3 | (5.6) | 1 | (5.0) | 3 | (7.3) | |
Presence of medical diagnosis n (%) | < 0.001* | ||||||||
Yes | 21 | (100.0) | 56 | (98.2) | 24 | (100) | 32 | (78.0) | |
No | 0 | (0.0) | 1 | (1.8) | 0 | (0.0) | 9 | (22.0) | |
Medication use n (%) | 0.66 | ||||||||
Yes | 21 | (100.0) | 53 | (93.0) | 23 | (95.8) | 38 | (90.5) | |
No | 0 | (0.0) | 4 | (7.0) | 1 | (4.2) | 4 | (9.5) | |
Preventive visit rate per year (First-Last visit)a, median (q1, q3) | 0.94 (0.32,1.53) | 0.63 (0.21,1.10) | 0.83 (0.43, 1.16) | 0.73 (0.29,1.00) | 0.551 | ||||
Preventive visit rate per year (First visit-Index date)b, median (q1, q3) | 1.32 (0.68, 2.23) | 0.72 (0.07, 2.00) | 1.00 (0.33, 4.00) | 1.17 (0.50, 2.53) | 0.458 | ||||